Request More Info

Oral cancer is 90% curable when found early, but 70% of oral cancers are diagnosed in the late stages. ViziLite Plus with TBlue is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. The product includes an acetic acid rinse, a chemiluminescent light source, and a blue phenothiazine dye to mark lesions identified by the light. According to the manufacturer, ViziLite Plus is designed to be used in a patient population at increased risk for oral cancer.